Transgenic mammals and methods of use thereof
US12049516B2 · kind B2 · utility
0Cited by
54References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 15, 2020 |
| Grant date | Jul 30, 2024 |
| Priority date | — |
| Expiry date | Nov 29, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to transgenic mammals that express canine-based immunoglobulins, including transgenic rodents that express canine-based immunoglobulins for the development of canine therapeutic antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.